Hangzhou Minsheng Healthcare Co., Ltd. (SHE:301507)
15.22
-0.20 (-1.30%)
Feb 2, 2026, 4:00 PM EST
SHE:301507 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 741.57 | 638.76 | 580.36 | 545.65 | 487.91 | 433.76 |
Other Revenue | 2.49 | 2.49 | 1.37 | 1.47 | 1.66 | 5.67 |
| 744.06 | 641.25 | 581.73 | 547.12 | 489.58 | 439.43 | |
Revenue Growth (YoY) | 20.85% | 10.23% | 6.33% | 11.75% | 11.41% | 25.38% |
Cost of Revenue | 365.43 | 288.19 | 225.42 | 219.47 | 169.18 | 156.82 |
Gross Profit | 378.62 | 353.06 | 356.32 | 327.65 | 320.4 | 282.6 |
Selling, General & Admin | 258.61 | 246.23 | 240.88 | 219.63 | 226.67 | 197.16 |
Research & Development | 24.73 | 23.98 | 29.56 | 27.17 | 24.07 | 17.3 |
Other Operating Expenses | 7.07 | 7.2 | 5.95 | 5.64 | 7.39 | 5.21 |
Operating Expenses | 290.39 | 278.08 | 277.3 | 252.25 | 258.51 | 219.81 |
Operating Income | 88.23 | 74.98 | 79.02 | 75.4 | 61.89 | 62.8 |
Interest Expense | - | -0.06 | -0.11 | -0.16 | -0.51 | -2.46 |
Interest & Investment Income | 23.93 | 29.5 | 13.98 | 8.79 | 10.48 | 6.25 |
Currency Exchange Gain (Loss) | -0.06 | -0.06 | - | - | - | - |
Other Non Operating Income (Expenses) | 1.46 | -0.82 | -0.12 | -0.08 | 6.97 | -8.07 |
EBT Excluding Unusual Items | 113.56 | 103.54 | 92.77 | 83.95 | 78.84 | 58.52 |
Gain (Loss) on Sale of Investments | 23.08 | -0.5 | 1.06 | -0.46 | -2.65 | 1.24 |
Gain (Loss) on Sale of Assets | -0 | - | - | -0 | 0.18 | 0.06 |
Asset Writedown | -0.61 | -0 | - | -0.27 | -0.29 | -0.19 |
Other Unusual Items | 3.22 | 3.22 | 2.98 | 4.85 | 2.86 | 2.79 |
Pretax Income | 139.25 | 106.25 | 96.8 | 88.07 | 78.94 | 62.42 |
Income Tax Expense | 18.51 | 14.42 | 11.16 | 9.06 | 8.71 | 11.71 |
Net Income | 120.07 | 91.83 | 85.63 | 79.01 | 70.22 | 50.72 |
Net Income to Common | 120.07 | 91.83 | 85.63 | 79.01 | 70.22 | 50.72 |
Net Income Growth | 33.21% | 7.24% | 8.38% | 12.51% | 38.46% | 16.08% |
Shares Outstanding (Basic) | 352 | 353 | 295 | 263 | 260 | 238 |
Shares Outstanding (Diluted) | 352 | 353 | 295 | 263 | 260 | 238 |
Shares Change (YoY) | -0.37% | 19.61% | 12.12% | 1.26% | 9.28% | - |
EPS (Basic) | 0.34 | 0.26 | 0.29 | 0.30 | 0.27 | 0.21 |
EPS (Diluted) | 0.34 | 0.26 | 0.29 | 0.30 | 0.27 | 0.21 |
EPS Growth | 33.70% | -10.35% | -3.33% | 11.11% | 26.70% | - |
Free Cash Flow | -13.29 | 13.57 | 72.08 | 68.37 | 18.75 | 82.82 |
Free Cash Flow Per Share | -0.04 | 0.04 | 0.24 | 0.26 | 0.07 | 0.35 |
Dividend Per Share | 0.100 | 0.100 | 0.100 | - | - | - |
Gross Margin | 50.89% | 55.06% | 61.25% | 59.89% | 65.44% | 64.31% |
Operating Margin | 11.86% | 11.69% | 13.58% | 13.78% | 12.64% | 14.29% |
Profit Margin | 16.14% | 14.32% | 14.72% | 14.44% | 14.34% | 11.54% |
Free Cash Flow Margin | -1.79% | 2.12% | 12.39% | 12.50% | 3.83% | 18.85% |
EBITDA | 105.94 | 96.52 | 105.66 | 106.79 | 91.42 | 91.22 |
EBITDA Margin | 14.24% | 15.05% | 18.16% | 19.52% | 18.67% | 20.76% |
D&A For EBITDA | 17.71 | 21.54 | 26.64 | 31.39 | 29.53 | 28.43 |
EBIT | 88.23 | 74.98 | 79.02 | 75.4 | 61.89 | 62.8 |
EBIT Margin | 11.86% | 11.69% | 13.58% | 13.78% | 12.64% | 14.29% |
Effective Tax Rate | 13.29% | 13.57% | 11.53% | 10.29% | 11.04% | 18.75% |
Revenue as Reported | 744.06 | 641.25 | 581.73 | 547.12 | - | - |
Advertising Expenses | - | 37.41 | 34.43 | 77.05 | 91.52 | 95.43 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.